Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Gynaecol Obstet. 2007 Oct;99(1):43-5. Epub 2007 Jun 29.

Effects of tibolone on health-related quality of life in menopausal women.

Author information

1
Department of Obstetrics and Gynecology, Vivekananda Institute of Medical Sciences, Calcutta, India. sudhin@vsnl.net

Abstract

OBJECTIVE:

The present study assessed improvements in health-related quality of life (HRQOL) in menopausal women using tibolone.

METHODS:

One hundred women who underwent surgical menopause for various benign gynecological conditions were advised to take tibolone (2.5 mg) daily. The Menopause Rating Scale (MRS II) was used to assess the change in HRQOL after 3 months and 12 months of treatment.

RESULTS:

Sixty-two women returned for follow-up after 3 months, while only 15 returned for after 12 months. Significant improvements in HRQOL were found after 3 months, and further improvements were obtained after 12 months, although at a slower rate. Among the three subscales of MRS, maximum improvement in the somatovegetative component and lesser improvements in the other two subscales were found.

CONCLUSION:

Tibolone is effective in improving the overall HRQOL of menopausal women. Somatovegetative symptoms show most improvement.

PMID:
17604031
DOI:
10.1016/j.ijgo.2007.04.029
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center